Malaysia vs Paraguay: HIV-positive TB patients on ART (antiretroviral therapy)
Malaysia
39.0%
in 2024
Paraguay
36.0%
in 2024
Malaysia rank
140th
Paraguay rank
143rd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malaysia
- Paraguay
How they compare
Malaysia currently reports 39.0% against 36.0% in Paraguay, a difference of 3.0%.
That makes Malaysia's figure about 1.1 times Paraguay's.
The two have swapped places 1 time across 17 shared years of data; in 2008 it was Paraguay ahead.
Malaysia ranks 140th and Paraguay ranks 143rd of 144 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.5% | 58.5% | 32.0% | Paraguay |
| 2010s | 37.1% | 79.4% | 42.3% | Paraguay |
| 2020s | 33.2% | 77.4% | 44.2% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malaysia or Paraguay?
- Malaysia, at 39.0% against 36.0% in Paraguay as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malaysia and Paraguay?
- 3.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Paraguay?
- 17 years are reported by both, from 2008 to 2024.
- How do Malaysia and Paraguay rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malaysia ranks 140th and Paraguay ranks 143rd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.